Literature DB >> 21482879

Slow resolution of clinically active trachoma following successful mass antibiotic treatments.

Jeremy D Keenan, Takele Lakew, Wondu Alemayehu, Muluken Melese, Jenafir I House, Nisha R Acharya, Travis C Porco, Bruce D Gaynor, Thomas M Lietman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482879      PMCID： PMC4984845          DOI： 10.1001/archophthalmol.2011.46

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

Authors:  N Fraser-Hurt; R L Bailey; S Cousens; D Mabey; H Faal; D C Mabey
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

2.  Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.

Authors:  Jeremy D Keenan; Takele Lakew; Wondu Alemayehu; Muluken Melese; Travis C Porco; Elizabeth Yi; Jenafir I House; Zhaoxia Zhou; Kathryn J Ray; Nisha R Acharya; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Authors:  R L Bailey; P Arullendran; H C Whittle; D C Mabey
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321

4.  Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.

Authors:  Muluken Melese; Wondu Alemayehu; Takele Lakew; Elizabeth Yi; Jenafir House; Jaya D Chidambaram; Zhaoxia Zhou; Vicky Cevallos; Kathryn Ray; Kevin Cyrus Hong; Travis C Porco; Isabella Phan; Ali Zaidi; Bruce D Gaynor; John P Whitcher; Thomas M Lietman
Journal:  JAMA       Date:  2008-02-20       Impact factor: 56.272

5.  Reduction and return of infectious trachoma in severely affected communities in Ethiopia.

Authors:  Takele Lakew; Jenafir House; Kevin C Hong; Elizabeth Yi; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Kathryn Ray; Stephanie Chin; Emmanuel Romero; Jeremy Keenan; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
  5 in total
  16 in total

1.  The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.

Authors:  Meron Haile; Zerihun Tadesse; Sintayehu Gebreselassie; Berhan Ayele; Teshome Gebre; Sun N Yu; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Paul M Emerson; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

Review 2.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

3.  Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection?

Authors:  Beatriz Munoz; Dianne Stare; Harran Mkocha; Charlotte Gaydos; Thomas Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

Review 4.  Trachoma: an update on prevention, diagnosis, and treatment.

Authors:  Satasuk Joy Bhosai; Robin L Bailey; Bruce D Gaynor; Thomas M Lietman
Journal:  Curr Opin Ophthalmol       Date:  2012-07       Impact factor: 3.761

5.  Risk factors for ocular chlamydia after three mass azithromycin distributions.

Authors:  Berhan Ayele; Teshome Gebre; Jeanne Moncada; Jenafir I House; Nicole E Stoller; Zhaoxia Zhou; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

6.  Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.

Authors:  Abdou Amza; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Sun N Yu; Zhaoxia Zhou; Stephanie Chin; Sheila K West; Robin L Bailey; David C W Mabey; Jeremy D Keenan; Travis C Porco; Thomas M Lietman; Bruce D Gaynor
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 7.  Stopping azithromycin mass drug administration for trachoma: A systematic review.

Authors:  Hamidah Mahmud; Emma Landskroner; Abdou Amza; Solomon Aragie; William W Godwin; Anna de Hostos Barth; Kieran S O'Brien; Thomas M Lietman; Catherine E Oldenburg
Journal:  PLoS Negl Trop Dis       Date:  2021-07-08

8.  The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.

Authors:  Jennifer S Lee; Beatriz E Muñoz; Harran Mkocha; Charlotte A Gaydos; Thomas C Quinn; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10

Review 9.  Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis.

Authors:  Meredith E Stocks; Stephanie Ogden; Danny Haddad; David G Addiss; Courtney McGuire; Matthew C Freeman
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

10.  Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.

Authors:  Jonathan D King; Tesfaye Teferi; Elizabeth A Cromwell; Mulat Zerihun; Jeremiah M Ngondi; Mesele Damte; Frew Ayalew; Zerihun Tadesse; Teshome Gebre; Ayelign Mulualem; Alemu Karie; Berhanu Melak; Mitku Adugna; Demelash Gessesse; Abebe Worku; Tekola Endashaw; Fisseha Admassu Ayele; Nicole E Stoller; Mary Rose A King; Aryc W Mosher; Tesfaye Gebregzabher; Geremew Haileysus; Peter Odermatt; Jürg Utzinger; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.